102 related articles for article (PubMed ID: 3166079)
21. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
22. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA).
Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN
Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970
[TBL] [Abstract][Full Text] [Related]
23. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
[TBL] [Abstract][Full Text] [Related]
24. In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
Kokenberg E; Sonneveld P; Delwel R; Sizoo W; Hagenbeek A; Löwenberg B
Leukemia; 1988 Aug; 2(8):511-7. PubMed ID: 3166077
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic importance of DNA histograms of bone marrow cells in acute myeloblastic leukemias].
Janowska-Wieczorek A; Maj S; Apel D
Acta Haematol Pol; 1981; 12(3-4):171-4. PubMed ID: 6952737
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen.
Tafuri A; De Felice L; Petrucci MT; Mascolo MG; Ricciardi MR; Ciliberti C; Martelli MP; Petti MC
Cytokines Mol Ther; 1995 Dec; 1(4):301-7. PubMed ID: 9384683
[TBL] [Abstract][Full Text] [Related]
27. Distribution and content of nuclear and cellular RNA among cell populations of acute lymphoblastic and nonlymphoblastic leukemia.
Walle AJ
Cancer Res; 1985 Oct; 45(10):5193-5. PubMed ID: 3861243
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia.
Eisele L; Klein-Hitpass L; Chatzimanolis N; Opalka B; Boes T; Seeber S; Moritz T; Flasshove M
Acta Haematol; 2007; 117(1):8-15. PubMed ID: 17095854
[TBL] [Abstract][Full Text] [Related]
29. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
[TBL] [Abstract][Full Text] [Related]
30. S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.
Powell BL; White JC; Gregory BW; Brockschmidt JK; Rhinehardt-Clark A; Lyerly ES; Chorley HM; Capizzi RL
Leukemia; 1991 Jul; 5(7):598-601. PubMed ID: 2072744
[TBL] [Abstract][Full Text] [Related]
31. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
[TBL] [Abstract][Full Text] [Related]
32. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
34. [Studies on cell kinetics in leukemia using flow cytometry].
Yoshida K
Hokkaido Igaku Zasshi; 1982 Sep; 57(5):557-71. PubMed ID: 7152463
[TBL] [Abstract][Full Text] [Related]
35. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
36. [Detection of glutathione S-transferase and lung resistance-related proteins in acute leukemia and its clinical significance].
Zhang ZM; Xie ZX; Tan DR; Huang CH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):292-4. PubMed ID: 16045016
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
38. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
39. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
40. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]